Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2005
10/19/2005CN1682721A Tropisetron hydrochloride oral disintegration tablet preparation and its preparing method
10/19/2005CN1682720A Berberine hydrochloride dispensing tablet and its preparing method
10/19/2005CN1682719A Enteric soluble coating slow releasing tablet containing huperzine A and preparing method
10/19/2005CN1682718A Telmisartan dispersing tablet and its preparing method
10/19/2005CN1682717A Medicinal preparation and its preparing method
10/19/2005CN1682716A External plaster for treating skin tinea and skin rhagas
10/19/2005CN1682715A Anti-anoxia medicinal composition
10/19/2005CN1682714A Composition for preventing cardiovascular system diseases
10/19/2005CN1682713A Use of ampelopsin in preparing medicine for treating diseases related with aldose reductase
10/19/2005CN1682712A Medicinal composition for treating bone metabolic disease
10/19/2005CN1682711A Medicinal composition with function of clearing away heat and toxic material
10/19/2005CN1682710A Water soluble soybean aglycone medicinal composition and its preparing method
10/19/2005CN1682709A Furosemide oral disintegration tablet and its preparing method
10/19/2005CN1682708A External use analgesic cream for transfusion
10/19/2005CN1682707A Pharmaceutical composition comprising fenofibrate and process for its preparation
10/19/2005CN1682706A Stable oil-in-water emulsion of propyl gallate for vein and its preparing method
10/19/2005CN1682705A Skin plaster containing aceclofenac
10/19/2005CN1682704A Levodopa nano preparation and its preparing method
10/19/2005CN1682703A Sterilizing gel
10/19/2005CN1682702A Method for preparing medicine composition capable of inhibiting post infective virus proteinase
10/19/2005CN1682701A Self microemulsifying preparation of curcumin and its preparing process
10/19/2005CN1682700A Beta-cyclodextrin/phenylpropanol inclusion and its preparing method
10/19/2005CN1682693A In site gel medicine transfer system for hardening treating angioma and vascular deformity
10/19/2005CN1682691A Process for preparing medicinal syrup
10/19/2005CN1682682A Hair tension and hardness improving agent
10/19/2005CN1223608C Caspase-8 interacting proteins
10/19/2005CN1223595C Triptolide alcohol derivative and its use
10/19/2005CN1223591C Piperazine oxime derivatives having Nk-1 receptor antagonistic activity
10/19/2005CN1223589C Potassium sodium dehydroandroandrographolide succinates and their preparations
10/19/2005CN1223578C Medical compound with antalgic, anti-inflammation and thrombocyte decoagulation function
10/19/2005CN1223375C Heat resisting lyophilized protectant for chicken infectious bronchitis H120, H52, Kidney infectious bronchitis W93 lyophilized vaccine and preparing process thereof
10/19/2005CN1223373C Sore throat relieving preparation
10/19/2005CN1223371C Preparation of effective component from rhodiola crenulate and preparing method
10/19/2005CN1223370C Medicine for treating internal and external hemorrhoids and its processing method
10/19/2005CN1223367C Ointment for treating brandy nose and face acne
10/19/2005CN1223360C Chinese medicine for treating qi obstruction in chest
10/19/2005CN1223352C Liposome ointment containing heparin kind medicine and its preparation method
10/19/2005CN1223351C Use of low-molecular-weight heparins for preventing and treating cerebral edemas
10/19/2005CN1223350C Pharmaceutical combination of ethinylestradiol and drospirenone for use as contraceptive
10/19/2005CN1223349C Drug combination for treatment of depression and related disorders comprising mirtazapine
10/19/2005CN1223348C N-(aryloxy group alkyl) heteroaromatic guadine and heteroaromatic guazine used as medicines
10/19/2005CN1223347C Aqueous cilostazol preparation for injection
10/19/2005CN1223346C Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
10/19/2005CN1223345C Pharmaceutical composition of anti-platelet aggregation
10/19/2005CN1223344C Parasiticides for farmed fish
10/19/2005CN1223343C Novel fatty analogues for the treatment of obesity, hypertension and fatty liver
10/19/2005CN1223342C Sucrose ester-C20-28 alcohol preparation
10/19/2005CN1223341C Spheroids, preparation method and pharmaceutical compositions
10/19/2005CN1223338C Cetirizine hydrochloride gel
10/18/2005US6957106 Implantable method to regulate blood pressure by means of coded nerve signals
10/18/2005US6956109 capable of crossing cell membranes, penetrating inside cells and mimicking various properties of the ceramides, particularly that of inducing apoptosis in human cancer cells
10/18/2005US6956062 Storage-stable compositions of glycerol monoalkyl ethers
10/18/2005US6956060 Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
10/18/2005US6956059 use in relief of rheumatoid arthritis, rheumatoid spondylitis, osteroarthritis, gouty arthritis and other arthritic conditions, inflamed joints, eczema and other inflammatory skin conditions, inflammatory eye conditions, aids, hiv
10/18/2005US6956058 Administering a diglyceride, especially of omega 3 unsaturated fatty acids; dietary therapy for a diabetic patient
10/18/2005US6956057 Treating ocular hypertension or glaucoma which comprises administering to an animal having ocular hypertension or glaucoma a therapeutically effective amount of a compound which is an EP4 agonist.
10/18/2005US6956056 Method for providing a cathartic effect
10/18/2005US6956054 Treatment of warm-blooded animals having a tumor or non-malignant hypervascularation, by administering a sufficient amount of a cytotoxic agent formulated into a phosphate prodrug form having substrate specificity for microvessel
10/18/2005US6956053 Mixtures of gastric juice secretion antagonist and proton pump inhibitors used for prophylaxis of eating disorders; cyclization
10/18/2005US6956052 treatment of cancer and inflammation-associated disorders, such as arthritis; for example,1-[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide
10/18/2005US6956050 Imidazole compounds as anti-inflammatory and analgesic agents
10/18/2005US6956049 Methods of modulating processes mediated by excitatory amino acid receptors
10/18/2005US6956048 Pharmaceutical emulsions for retroviral protease inhibitors
10/18/2005US6956047 useful in the treatment of central nervous system disorders and stress-related disorders.
10/18/2005US6956045 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents
10/18/2005US6956044 5-Methy-1-phenyl-2(1H)-pyridone (pirfenidone) and5-ethyl-1-phenyl-2-(1H)-pyridone as antiepipeptic and -convulsant agents; side effect reduction; bioavailability;high speed; efficiency
10/18/2005US6956043 Pharmaceutical compositions comprising 33-epi-chloro-33-desoxy-ascomycin solid dispersions
10/18/2005US6956042 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
10/18/2005US6956041 Protein kinase inhibitors
10/18/2005US6956037 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/18/2005US6956036 6-hydroxy-indazole derivatives for treating glaucoma
10/18/2005US6956033 3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient
10/18/2005US6956031 Therapy for estrogen sensitive disease; anticancer agents
10/18/2005US6956030 Treating disease of the airway passages and lungs such as asthma and allergic rhinitis by administering intranasally or oral inhalation; low bioavailability and low systemic side-effects; aerosols
10/18/2005US6956028 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging
10/18/2005US6956023 Materials and methods for providing nutrition to neonates
10/18/2005US6955883 Life sciences business systems and methods
10/18/2005US6955873 kit comprises buccal swab for obtaining DNA sample for allelic analysis; comprises signal transmitter precursor, enhancer of precursor uptake, and inhibitor of neurotransmitter reuptake/signal transmitter catabolism; attention deficit disorder
10/18/2005US6955825 Compositions and methods for high sorption of skin materials and delivery of sulfur
10/18/2005US6955821 Sustained release formulations of guaifenesin and additional drug ingredients
10/18/2005US6955816 Anti-aging skin care composition and uses thereof
10/18/2005US6955815 Combinations for the treatment of inflammatory disorders
10/18/2005US6955814 protecting and/or preserving organs, in particular the heart during open-heart surgery, cardiovascular diagnosis or therapeutic intervention by administering potassium channel opener or agonist and adenosine receptor agonist and local anesthetic
10/18/2005US6955812 Health food and preparation having an anti-obesity effect
10/18/2005US6955806 For therapy of microbial infection in mammal
10/18/2005US6955804 Controlling melanin in melanocytes comprising applying mixtures of alcohols such as 5-norbornene-2,2-dimethanol, prodrugs and carriers; prophylaxis of skin disorders
10/18/2005CA2460970C Processes for preparing crystalline and amorphous mupirocin calcium
10/18/2005CA2369093C Anticonvulsant derivatives useful in lowering lipids
10/18/2005CA2340138C 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/18/2005CA2340054C Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles
10/18/2005CA2339273C Branched alkyl pyrrolidine-3-carboxylic acids
10/18/2005CA2335451C Process and product for promoting weight loss in overweight dogs
10/18/2005CA2334702C Pharmaceutical compositions and uses for androst-5-ene-3.beta.,17.beta.-diol
10/18/2005CA2333160C Additives for crustacean or fish feeds and feeds
10/18/2005CA2331464C Platinum complex, its preparation and therapeutic application
10/18/2005CA2329075C Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists
10/18/2005CA2295063C Indole compounds as anti-inflammatory/analgesic agents
10/18/2005CA2294171C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
10/18/2005CA2285633C Bacterial plasmids
10/18/2005CA2282082C Microgranules containing cisplatin
1 ... 4502 4503 4504 4505 4506 4507 4508 4509 4510 4511 4512 4513 4514 4515 4516 4517 4518 4519 4520 4521 4522 ... 7860